InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-03-27 00:00:00 ET · period of report 2024-03-25 · accession 0001415889-24-009214 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-27 2024-03-25 PCVX PICKERING GRANT CEO, Dir M - OptEx $1.79 +15.0K 492.8K +3% +$26.9K
DM 2024-03-27 2024-03-25 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $66.94 -15.0K 479.4K -3% -$1.00M
D 2024-03-27 2024-03-25 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -15.0K 15.2K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-25 M A 15,000 $1.79 492,847 D — —
2 Common Common Stock 2024-03-25 S D 1,550 $67.50 477,847 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $67.415 to $67.695. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-03-25 S D 13,450 $66.87 479,397 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $66.42 to $67.405. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2024-03-25 M D 15,000 $0.00 15,225 D $1.79 · — to 2027-05-17 15,000 Common Stock (F6) Stock Option is fully vested and exercisable.